Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-week randomized double-blind study of inhaled AZD4818 in COPD
2007-003962-16Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD4818 arm with Placebo arm (2 arms). Primary endpoint: Tolerability and safety. Started Oct 2007; status: completed.
02
Drugs
azd-4818
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-003962-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003962-16.